3 Top Stocks With Estimated Discounts Up To 40.6% Below Intrinsic Value

In the last week, the United States market has experienced a 2.2% decline, yet it has risen by 13% over the past year with earnings projected to grow by 17% annually. In this environment, identifying stocks that are trading at significant discounts to their intrinsic value can present compelling opportunities for investors seeking potential growth and value.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Valley National Bancorp (VLY)	$13.85	$27.10	48.9%
Pegasystems (PEGA)	$35.72	$70.66	49.4%
Old National Bancorp (ONB)	$25.60	$51.00	49.8%
Northeast Bank (NBN)	$131.22	$246.98	46.9%
Futu Holdings (FUTU)	$113.51	$211.32	46.3%
Civista Bancshares (CIVB)	$27.35	$53.11	48.5%
Capital Bancorp (CBNK)	$36.36	$66.80	45.6%
Autodesk (ADSK)	$211.61	$413.81	48.9%
Alliance Entertainment Holding (AENT)	$5.51	$10.53	47.7%
Addus HomeCare (ADUS)	$118.52	$226.18	47.6%

Click here to see the full list of 51 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

Healthcare Services Group (HCSG)

Overview: Healthcare Services Group, Inc. offers management, administrative, and operational services to various departments in nursing homes, retirement complexes, rehabilitation centers, and hospitals across the United States with a market cap of approximately $1.51 billion.

Operations: The company generates revenue from two main segments: Dietary services, contributing $1.02 billion, and Environmental Services (EVS), which accounts for $844.06 million.

Estimated Discount To Fair Value: 36.7%

Healthcare Services Group is trading at US$21.84, significantly below its estimated future cash flow value of US$34.52, indicating potential undervaluation. Recent earnings showed a substantial turnaround with net income rising to US$22.7 million from a loss last year, despite forecasts of declining earnings by 13.4% annually over the next three years. The company also completed a share buyback worth US$35.64 million but experienced significant insider selling recently and was dropped from the Russell 2000 Dynamic Index.

• Our comprehensive growth report raises the possibility that Healthcare Services Group is poised for substantial financial growth.
• Dive into the specifics of Healthcare Services Group here with our thorough financial health report.

MYR Group (MYRG)

Overview: MYR Group Inc., with a market cap of $4.47 billion, operates through its subsidiaries to offer electrical construction services in the United States and Canada.

Operations: The company's revenue is primarily derived from its Commercial & Industrial (C&I) segment, generating $1.91 billion, and its Transmission & Distribution (T&D) segment, contributing $2.10 billion.

Estimated Discount To Fair Value: 40.6%

MYR Group is trading at US$284.47, well below its estimated future cash flow value of US$478.82, highlighting significant undervaluation. The company's earnings are projected to grow faster than the market at 17.6% annually, though revenue growth lags behind the market average. Recent financing agreements enhance liquidity with a new US$690 million revolving credit facility and term loans for strategic expansions and acquisitions, supporting potential growth opportunities despite slower revenue projections.

• According our earnings growth report, there's an indication that MYR Group might be ready to expand.
• Navigate through the intricacies of MYR Group with our comprehensive financial health report here.

Photronics (PLAB)

Overview: Photronics, Inc. is a company that manufactures and sells photomask products and services across various regions including the United States, Taiwan, China, Korea, Europe, and internationally with a market cap of approximately $1.72 billion.

Operations: The company's revenue is primarily derived from its photomask manufacturing segment, which generated $866.82 million.

Estimated Discount To Fair Value: 16.3%

Photronics, Inc. is trading at US$28.38, slightly below its estimated future cash flow value of US$33.91, suggesting some undervaluation based on cash flows. Despite a 52% increase in earnings over the past year and strong recent quarterly results with net income rising to US$28.92 million, future earnings are expected to decline by 13.4% annually over the next three years amid legal challenges and slower revenue growth compared to the market average.

• Our expertly prepared growth report on Photronics implies its future financial outlook may be stronger than recent results.
• Click here and access our complete balance sheet health report to understand the dynamics of Photronics.

Seize The Opportunity

• Dive into all 51 of the Undervalued US Stocks Based On Cash Flows we have identified here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com